Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (115)

Latest Posts

About This Stock More About This Stock
5 Best Biotech Bets Likely To Outperform Estimates In Q4
Article By: Zacks Investment Research
Wednesday, January 23, 2019 2:06 PM EST
There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.
In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO
Thirteen Companies Boosting Distributions For Long-Term Shareholders
Article By: Dividend Growth Investor
Monday, December 17, 2018 1:16 PM EST
An increase that is well below the rate of dividend growth indicates caution, while an increase that is close to or higher than the average indicates optimism.
In this article: O, BEN, T, AMGN, ERIE, GGG, THG, PFE, ABT, D, UBA, WM, VTR
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Is Now A Good Time To Buy Amgen?
Article By: Andres Cardenal
Monday, September 24, 2018 2:05 PM EST
Amgen is a high-quality business generating strong cash flows. From a quantitative perspective, the numbers bode well for investors in Amgen going forward.
In this article: AMGN Also: NVO, IBB, BIIB, CELG
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EST
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB


Latest Tweets for $AMGN

No tweets yet!


July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments